Paul Milligan

Paul Milligan has been the System Medication Safety Pharmacist for BJC HealthCare, a diverse 15-hospital system located in St. Louis, Missouri, and Clinical Lead for the Adverse Drug Event Preventable Harm Initiative since 2008. Like many of his colleagues, Dr. Milligan’s role has expanded to include service to patients during the COVID-19 pandemic, helping to set up and coordinate a remote COVID testing site, and monitoring adverse drug events from the vaccine, and related therapies. He earned his Pharm.D. from the University of Kansas and his B.S.Pharm. from St. Louis College of Pharmacy. 

Dr. Milligan has served as Director-at-Large for the ASHP Section of Inpatient Care Practitioner’s Executive Committee, and been awarded the ASHP Foundation awards for Excellence in Medication Use Safety and for outstanding contribution to biomedical literature. Currently, he is a manuscript reviewer for the Best Practices Award, and proud member of the Section’s Advisory Group on Medication Safety. 

Dr. Milligan has published over 30 manuscripts and speaks regularly at meetings and webinars in the areas of medication safety, pandemic management, change management, and continuous respiratory monitoring. He has practiced pharmacy for over 25 years, mostly as an inpatient clinical pharmacist, anticoagulant clinician, and researcher. He even owned a Medicine Shoppe Pharmacy.